Adaptyv raised a $40M Series A to build the automated lab for agentic biology, led by Highland Europe with existing investors Ace Ventures, ByFounders and Y Combinator doubling down.
Last week, Adaptyv shared our work with Anthropic. Claude designed proteins, sent them to our automated wet lab, and got real experimental data back.
Over the past year Adaptyv have grown its lab throughput by over 5x and onboarded more than 100 customers, ranging from bio AI labs like Chai Discovery and Boltz to pharmas like Roche and Novo Nordisk to dozens and dozens of new startups that use AI to radically speed up drug discovery.
Now Adaptyv is scaling: doubling its team in Lausanne and opening a new office and lab in London in Q4 2026.
